ZN-c5

DRUG5 trials

Sponsors

Zeno Alpha Inc., Zentera Therapeutics HK Limited

Conditions

Breast CancerBreast NeoplasmsHealthy

Phase 1

A Study of ZN-c5 in Subjects With Breast Cancer

CompletedNCT03560531

Zeno Alpha Inc.Breast Cancer

Start: 2018-11-30End: 2022-12-22Updated: 2024-08-09

A Study of ZN-c5 in Participants With Breast Cancer

CompletedNCT04176757

Zeno Alpha Inc.Breast Cancer

Start: 2020-01-03End: 2021-05-25Updated: 2022-08-01

A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

CompletedNCT04514159

Zeno Alpha Inc.Breast Cancer

Start: 2020-11-12End: 2022-10-24Updated: 2023-02-01

A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects

CompletedNCT04561752

Zeno Alpha Inc.Healthy

Start: 2020-11-02End: 2020-12-16Updated: 2020-12-23

A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS

CompletedNCT04852419

Zentera Therapeutics HK LimitedBreast Neoplasms

Start: 2021-05-31End: 2022-06-23Updated: 2022-08-11